- Carbonyl-reducing enzymes as targets of a drug-immobilised affinity carrier2015 | Farmaceutická fakulta v Hradci Králové
- The role of carbonyl reducing enzymes in oxcarbazepine in vitro metabolism in man2014 | Farmaceutická fakulta v Hradci Králové
- In vitro metabolism of fenofibric acid by carbonyl reducing enzymes2016 | Farmaceutická fakulta v Hradci Králové
- Reductive metabolism of tiaprofenic acid by the human liver and recombinant carbonyl reducing enzymes2017 | Farmaceutická fakulta v Hradci Králové
- Modulation of carbonyl reducing enzymes by xenobiotics2003 | Farmaceutická fakulta v Hradci Králové
- Cyclin-dependent kinase inhibitors AZD5438 and R547 show potential for enhancing efficacy of daunorubicin-based anticancer therapy: Interaction with carbonyl-reducing enzymes and ABC transporters2019 | Farmaceutická fakulta v Hradci Králové
- The role of carbonyl reducing enzymes in biotransformation of xenobioticsPublikace bez příslušnosti k fakultě
- Mebendazole anthelmintic therapy affects carbonyl reducing enzymes in pheasantPublikace bez příslušnosti k fakultě
- A simple identification of novel carbonyl reducing enzymes in the metabolism of the tobacco specific carcinogen NNK2012 | Farmaceutická fakulta v Hradci Králové
- Human microsomal carbonyl reducing enzymes in the metabolism of xenobiotics: well-known and promising members of the SDR superfamily2012 | Farmaceutická fakulta v Hradci Králové
- Efficient isolation of carbonyl-reducing enzymes using affinity approach with anticancer drug oracin as a specific ligand2013 | Farmaceutická fakulta v Hradci Králové
- Role of carbonyl reducing enzymes in the phase I biotransformation of the non-steroidal anti-inflammatory drug nabumetone in vitro2013 | Farmaceutická fakulta v Hradci Králové
- Modulace enzymů redukujících karbonylovou skupinu anthelmintickou terapií flubendazolem u prasete (Sus scrofa domestica) a bažanta (Phasianus colchicus)2008 | Ústřední knihovna
- Modulation of porcine (Sus scrofa domestica) and pheasant (Phasianus colchicus) carbonyl reducing enzymes by anthelmintic therapy with flubendazole2008 | Ústřední knihovna, Farmaceutická fakulta v Hradci Králové
- Activity of carbonyl reducing enzymes towards selected pharmacologically and toxicologically relevant substratesPublikace bez příslušnosti k fakultě
- Modulation of porcine and pheasant carbonyl reducing enzymes by anthelmintic therapy with flubendazolePublikace bez příslušnosti k fakultě
- Effects of selected cytostatic drugs on carbonyl reducing enzymes in human breast carcinoma MCF-7 cellsPublikace bez příslušnosti k fakultě
- Pharmacokinetic interactions of breast cancer chemotherapeutics with human doxorubicin reductases2015 | Farmaceutická fakulta v Hradci Králové
- Interactions of antileukemic drugs with daunorubicin reductases: could reductases affect the clinical efficacy of daunorubicin chemoregimens?2020 | Farmaceutická fakulta v Hradci Králové
- Carbonyl reduction pathways in drug metabolism2014 | Farmaceutická fakulta v Hradci Králové
- Carbonyl reduction of warfarin: Identification and characterization of human warfarin reductases2016 | Farmaceutická fakulta v Hradci Králové
- Buparlisib is a novel inhibitor of daunorubicin reduction mediated by aldo-keto reductase 1C32019 | Farmaceutická fakulta v Hradci Králové
- Deeper Insight into the Reducing Biotransformation of Bupropion in the Human LiverPublikace bez příslušnosti k fakultě
- Deeper Insight into the Reducing Biotransformation of Bupropion in the Human Liver2014 | Farmaceutická fakulta v Hradci Králové
- Nerolidol and Farnesol Inhibit Some Cytochrome P450 Activities but Did Not Affect Other Xenobiotic-Metabolizing Enzymes in Rat and Human Hepatic Subcellular Fractions2017 | Farmaceutická fakulta v Hradci Králové
- Olaparib Synergizes the Anticancer Activity of Daunorubicin via Interaction with AKR1C32020 | Farmaceutická fakulta v Hradci Králové
- The inhibitory effects of beta-caryophyllene, beta-caryophyllene oxide and alpha-humulene on the activities of the main drug-metabolizing enzymes in rat and human liver in vitro2017 | Farmaceutická fakulta v Hradci Králové
- The metabolism of flubendazole and the activities of selected biotransformation enzymes in Haemonchus contortus strains susceptible and resistant to anthelmintics2012 | Farmaceutická fakulta v Hradci Králové
- Targeting Pharmacokinetic Drug Resistance in Acute Myeloid Leukemia Cells with CDK4/6 Inhibitors2020 | Farmaceutická fakulta v Hradci Králové, Lékařská fakulta v Hradci Králové
- Isocitrate dehydrogenase 2 inhibitor enasidenib synergizes daunorubicin cytotoxicity by targeting aldo-keto reductase 1C3 and ATP-binding cassette transporters2022 | Farmaceutická fakulta v Hradci Králové